Published in Behav Brain Sci on December 01, 2012
What works to address prejudice? Look to developmental science research for the answer. Behav Brain Sci (2012) 0.81
Prejudicial behavior: more closely linked to homophilic peer preferences than to trait bigotry. Behav Brain Sci (2012) 0.80
History, prejudice, and the study of social inequities. Behav Brain Sci (2012) 0.79
Are attitudes the problem, and do psychologists have the answer? Relational cognition underlies intergroup relations. Behav Brain Sci (2012) 0.78
Traditional prejudice remains outside of the WEIRD world. Behav Brain Sci (2012) 0.78
Insights from studying prejudice in the context of American atheists. Behav Brain Sci (2012) 0.78
Echoing the call to move "beyond prejudice" in search of intergroup equality. Behav Brain Sci (2012) 0.78
Beyond prejudice to prejudices. Behav Brain Sci (2012) 0.78
The dominance of the individual in intergroup relations research: understanding social change requires psychological theories of collective and structural phenomena. Behav Brain Sci (2012) 0.78
All about us, but never about us: the three-pronged potency of prejudice. Behav Brain Sci (2012) 0.78
Prejudice and personality: a role for positive-approach processes? Behav Brain Sci (2012) 0.78
Prejudice reduction, collective action, and then what? Behav Brain Sci (2012) 0.78
Understanding the psychological processes involved in the demobilizing effects of positive cross-group contact. Behav Brain Sci (2012) 0.77
What's so crummy 'bout peace, love, and understanding? Behav Brain Sci (2012) 0.77
Statistical learning and prejudice. Behav Brain Sci (2012) 0.77
Heterosexism, homonegativity, and the sociopolitical dangers of orthodox models of prejudice reduction. Behav Brain Sci (2012) 0.77
From extreme emotions to extreme actions: explaining non-normative collective action and reconciliation. Behav Brain Sci (2012) 0.77
The politics of moving beyond prejudice. Behav Brain Sci (2012) 0.77
What's so insidious about "Peace, Love, and Understanding"? A system justification perspective. Behav Brain Sci (2012) 0.77
The dangers of prejudice reduction interventions: empirical evidence from encounters between Jews and Arabs in Israel. Behav Brain Sci (2012) 0.77
Liking more or hating less? A modest defence of intergroup contact theory. Behav Brain Sci (2012) 0.77
Prejudice is about politics: a collective action perspective. Behav Brain Sci (2012) 0.77
Prejudice in context departs from attitudes toward groups. Behav Brain Sci (2012) 0.77
Of babies and bathwater, and rabbits and rabbit holes: a plea for conflict prevention, not conflict promotion. Behav Brain Sci (2012) 0.77
You say you want a revolution? Behav Brain Sci (2012) 0.77
Faustian bargains for minorities within group-based hierarchies. Behav Brain Sci (2012) 0.77
Inequality is a relationship. Behav Brain Sci (2012) 0.77
Beyond prejudice: are negative evaluations the problem and is getting us to like one another more the solution? Behav Brain Sci (2012) 18.61
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst (2002) 4.33
Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med (2004) 4.30
Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA (2004) 4.18
Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr (2003) 3.34
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A (2005) 3.30
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med (2002) 2.90
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A (2007) 2.71
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst (2003) 2.51
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A (2008) 2.50
Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int (2009) 2.46
The Kitty Genovese murder and the social psychology of helping: the parable of the 38 witnesses. Am Psychol (2007) 2.23
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. J Clin Oncol (2007) 2.15
Validation of the HIV/AIDS Stigma Instrument - PLWA (HASI-P). AIDS Care (2007) 2.14
Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism (2009) 2.14
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol (2005) 2.06
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med (2011) 1.98
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One (2010) 1.92
High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med (2014) 1.91
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ (2005) 1.89
Human adrenal glands secrete vitamin C in response to adrenocorticotrophic hormone. Am J Clin Nutr (2007) 1.60
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res (2010) 1.57
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol (2005) 1.54
Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53
Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J (2006) 1.53
Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ (2004) 1.51
Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg (2005) 1.49
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ (2004) 1.46
Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 1.46
Intravenously administered vitamin C as cancer therapy: three cases. CMAJ (2006) 1.43
Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell (2007) 1.41
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. J Clin Oncol (2005) 1.40
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One (2012) 1.35
Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J Clin Invest (2010) 1.33
The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care (2009) 1.30
Evaluation of a health setting-based stigma intervention in five African countries. AIDS Patient Care STDS (2009) 1.29
Everyone for themselves? A comparative study of crowd solidarity among emergency survivors. Br J Soc Psychol (2008) 1.28
Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum Genet (2004) 1.27
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med (2011) 1.27
Lessons learned from the Decision Board: a unique and evolving decision aid. Health Expect (2000) 1.25
Beyond the optimal contact strategy: a reality check for the contact hypothesis. Am Psychol (2005) 1.18
Cooperation versus competition in a mass emergency evacuation: a new laboratory simulation and a new theoretical model. Behav Res Methods (2009) 1.17
6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways. J Biol Chem (2004) 1.16
Genomic and functional analysis of the sodium-dependent vitamin C transporter SLC23A1-SVCT1. Genes Nutr (2007) 1.16
Measuring HIV stigma for PLHAs and nurses over time in five African countries. SAHARA J (2009) 1.14
Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist (2003) 1.13
Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose. J Biol Chem (2002) 1.13
Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg (2006) 1.12
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol (2005) 1.11
Standard-dose vs high-dose multivitamin supplements for HIV. JAMA (2013) 1.08
Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am J Epidemiol (2005) 1.08
Radiation therapy and tamoxifen: concurrent or sequential? That is the question. J Clin Oncol (2004) 1.06
Cloning and functional characterization of the mouse fructose transporter, GLUT5. Biochim Biophys Acta (2002) 1.05
Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int (2010) 0.99
Come together: two studies concerning the impact of group relations on personal space. Br J Soc Psychol (2009) 0.99
The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. Am J Hum Genet (2005) 0.98
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal (2013) 0.97
Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr Cancer (2008) 0.96
Vitamins C and E and the prevention of preeclampsia. N Engl J Med (2006) 0.96
The experience of conducting Mortality and Morbidity reviews in a pediatric interventional radiology service: a retrospective study. J Vasc Interv Radiol (2008) 0.93
Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). FASEB J (2003) 0.92
Does perceived HIV stigma contribute to nurses' intent to migrate in five African countries? J Assoc Nurses AIDS Care (2010) 0.92
Bystander responses to a violent incident in an immersive virtual environment. PLoS One (2013) 0.90
Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer. Ann Intern Med (2014) 0.88
Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J Biol Chem (2013) 0.88
Fruit and vegetables: think variety, go ahead, eat! Am J Clin Nutr (2008) 0.87
Evidence-based approach to the introduction of positron emission tomography in ontario, Canada. J Clin Oncol (2009) 0.87
Contact and the ecology of racial division: some varieties of informal segregation. Br J Soc Psychol (2003) 0.86
Vitamin C in mouse and human red blood cells: an HPLC assay. Anal Biochem (2012) 0.86
Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. Arch Biochem Biophys (2004) 0.86
Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo. Leuk Lymphoma (2012) 0.86
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2003) 0.85
Comparative effectiveness research in oncology: an overview. J Clin Oncol (2012) 0.85
Prostate imaging modalities that can be used for complementary and alternative medicine clinical studies. Urol Clin North Am (2011) 0.83
Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation. Arterioscler Thromb Vasc Biol (2003) 0.83
Advice-giving difficulties in voluntary counselling and testing: a distinctly moral activity. AIDS Care (2011) 0.83
Measurement of plasma volume using fluorescent silica-based nanoparticles. J Appl Physiol (1985) (2011) 0.83
Comment re: Vitamin C antagonizes the cytotoxic effects of chemotherapy. Cancer Res (2009) 0.82
Social meaning of ambiguous sounds influences retrospective duration judgments. Psychol Sci (2013) 0.81
Vitamin C: working on the x-axis. Am J Clin Nutr (2009) 0.81
Is everyone Irish on St Patrick's Day? Divergent expectations and experiences of collective self-objectification at a multicultural parade. Br J Soc Psychol (2013) 0.80
Helping to improve the group stereotype: on the strategic dimension of prosocial behavior. Pers Soc Psychol Bull (2007) 0.80
Ocular surface squamous neoplasia in an anophthalmic socket 60 years after enucleation. Surv Ophthalmol (2011) 0.80
More evidence that locoregional radiation therapy improves survival: what should we do? J Natl Cancer Inst (2005) 0.79
Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Chest (2005) 0.79
Intergroup contact and attitudes toward the principle and practice of racial equality. Psychol Sci (2007) 0.79
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res (2012) 0.79
Epilogue: the peril and the promise of comparative effectiveness research in oncology. J Clin Oncol (2012) 0.78
Imaging: PET-CT imaging in non-small-cell lung cancer. Nat Rev Clin Oncol (2009) 0.78
The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Support Care Cancer (2003) 0.78
Antioxidant supplements and cardiovascular disease in men. JAMA (2009) 0.77
Structures of a pan-specific antagonist antibody complexed to different isoforms of TGFβ reveal structural plasticity of antibody-antigen interactions. Protein Sci (2014) 0.77
Economics of preoperative radiotherapy with total mesorectal excision: what can we learn from the Dutch experience? J Clin Oncol (2003) 0.77